Intrinsic Value of S&P & Nasdaq Contact Us

Novo Nordisk A/S NONOF OTC

Other OTC • Healthcare • Biotechnology • DK • USD

SharesGrow Score
87/100
6/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Novo Nordisk A/S (NONOF) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 1 Strong Buy, 17 Buy, 4 Hold, 3 Sell.

NONOF Analyst Ratings

Buy
25
Ratings
18 Buy
4 Hold
3 Sell
Based on 25 analysts giving stock ratings to Novo Nordisk A/S in the past 3 months
Rating breakdown
Strong Buy
1 4%
Buy
17 68%
Hold
4 16%
Sell
3 12%
72%
Buy
18 analysts
16%
Hold
4 analysts
12%
Sell
3 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message